Arundathy N. Pandite
CIK 1827232 · Chief Medical Officer · last filed 2026-05-14
Arundathy N. Pandite is a Chief Medical Officer who has filed 15 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider sold $198.3K of STTK on May 14, 2026. Across all open-market trades the lifetime net is −$198.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $821.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$821.1K
2
15
-$198.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STTK | Chief Medical Officer | 166,219 | $4.94 | $821.1K | -$198.3K | 13 | 2026-05-14 |
| Codiak BioSciences, Inc. (CDAK) Delisted | Director | — | $0.06 | — | $0 | 2 | 2022-06-21 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | STTK | Sell (S) | −30,000 | -$198.3K | EDGAR |
| 2026-01-27 | STTK | Tax (F) | −3,195 | -$13.3K | EDGAR |
| 2026-01-13 | STTK | Mixed | −6,851 | -$32.5K | EDGAR |
| 2025-01-28 | STTK | Mixed | −3,211 | -$3.7K | EDGAR |
| 2025-01-13 | STTK | Tax (F) | −6,884 | -$8.2K | EDGAR |
| 2024-01-31 | STTK | Tax (F) | −2,920 | -$29.2K | EDGAR |
| 2024-01-16 | STTK | Mixed | +43,488 | -$30.1K | EDGAR |
| 2023-01-27 | STTK | Grant (A) | +37,875 | $0 | EDGAR |
| 2023-01-12 | STTK | Tax (F) | −2,987 | -$9.1K | EDGAR |
| 2022-06-21 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |